Vanda Pharmaceuticals Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 4.55M35.71M31.27M32.73M33.88M50.16M109.92M146.02M165.08M193.12M227.19M248.17M268.68M254.38M192.64M198.77M
Cost of Revenue 1.92M2.89M0.13M1.58M23.46M24.71M17.85M20.51M24.49M23.36M25.63M24.28M14.80M11.31M
Gross Profit 2.63M32.82M31.27M32.60M33.88M48.57M86.46M121.31M147.24M172.61M202.70M224.80M243.05M230.10M177.84M187.46M
Operating items
Amortization - Intangibles 0.98M1.50M1.50M1.50M1.50M2.25M12.97M10.93M1.75M1.53M1.50M1.48M1.48M1.52M2.09M7.27M
Depreciation & Amortization - Total 0.94M1.23M1.43M1.40M1.40M1.40M1.22M0.92M0.90M
Research & Development 13.87M12.34M29.00M45.76M28.50M19.23M29.14M29.16M38.55M43.59M48.65M55.58M75.36M85.77M76.82M74.43M
Selling, General & Administrative 23.72M10.15M11.49M14.52M25.08M84.64M84.53M99.79M123.84M105.75M129.74M140.51M124.05M136.49M112.88M146.41M
Other Operating Expenses 2.90M4.39M1.50M1.62M41.05M77.62M36.43M34.71M18.36M20.61M24.59M23.44M25.71M24.58M15.97M17.69M
Operating Expenses 40.50M26.87M41.98M61.91M55.08M30.09M150.11M164.59M181.99M171.38M204.38M220.93M226.52M248.05M206.59M239.43M
Operating Income -35.95M8.84M-10.71M-29.18M-21.20M20.06M-40.19M-18.57M-16.90M21.74M22.81M27.24M42.16M6.33M-13.95M-40.66M
EBIT -35.95M8.84M-10.71M-29.18M-21.20M20.06M-40.19M-18.57M-16.90M21.74M22.81M27.24M42.16M6.33M-13.95M-40.66M
Non-operating items
Interest & Investment Income 0.09M0.43M0.46M
Non Operating Income -0.10M0.14M
Net income details
EBT -35.86M9.27M-10.25M-28.62M-21.05M20.19M-39.87M-17.91M-15.43M25.35M29.03M31.66M42.36M11.30M6.34M-22.92M
Tax Provisions 2.41M-1.15M0.10M0.14M0.14M-86.53M8.32M9.21M5.03M3.83M-4.02M
Profit After Tax -35.86M7.19M-9.80M-28.62M-21.05M20.19M-39.87M-18.01M-15.57M25.21M115.55M23.34M33.15M6.28M2.51M-18.90M
Income from Continuing Operations -35.86M6.86M-9.10M-28.62M-21.05M20.19M-39.87M-18.01M-15.57M25.21M115.55M23.34M33.15M6.28M2.51M-18.90M
Consolidated Net Income -35.86M6.86M-9.10M-28.62M-21.05M20.19M-39.87M-18.01M-15.57M25.21M115.55M23.34M33.15M6.28M2.51M-18.90M
Income towards Parent Company -35.86M6.86M-9.10M-28.62M-21.05M20.19M-39.87M-18.01M-15.57M25.21M115.55M23.34M33.15M6.28M2.51M-18.90M
Net Income towards Common Stockholders -35.86M6.86M-9.10M-28.62M-21.05M20.19M-39.87M-18.01M-15.57M25.21M115.55M23.34M33.15M6.28M2.51M-18.90M
Additional items
EPS (Basic) -0.00M0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.00M0.00M0.00M0.00M0.00M0.00M0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.00M0.00M0.00M0.00M0.00M0.00M0.00M-0.00M
Shares Outstanding (Weighted Average) 27.20M28.04M28.12M28.23M33.19M33.90M42.82M43.95M44.93M52.45M53.34M54.69M55.71M56.79M57.53M58.31M
Shares Outstanding (Diluted Average) 27.02M28.53M28.11M28.23M30.35M36.69M42.25M43.45M44.74M53.05M54.85M55.19M56.92M56.98M57.56M58.15M
EBITDA -35.95M8.84M-10.71M-29.18M-21.20M20.06M-40.19M-17.64M-15.67M23.17M24.21M28.64M43.56M7.55M-13.03M-39.76M
Tax Rate 26.03%11.23%0.54%26.28%21.74%44.47%60.42%17.54%